UPB.OQ - Upstream Bio Inc
Upstream Bio Inc
William Blair & Company

Phase III Plans Outlined With Higher Quarterly Dosing Regimen Aimed at Best-in-Class Efficacy for Differentiated Profile

公司
UPB.OQ
日期
2026-03-26
分析师
Matt Phipps, PHD
页数
8
需要登录
请登录后购买研报或生成音频内容。